Molecular characterization of the immune response to factor VIII. (Q34181248)

31 July 2017

1 reference

title

Molecular characterization of the immune response to factor VIII. (English)

1 reference

31 July 2017

Molecular Characterization of the Immune Response to Factor VIII (English)

0 references

author name string

Pete Lollar

series ordinal

1 reference

31 July 2017

language of work or name

1 reference

1 August 2002

1 reference

31 July 2017

August 2002

0 references

published in

Vox Sanguinis

1 reference

31 July 2017

volume

83 Suppl 1

1 reference

31 July 2017

0 references

page(s)

403-408

1 reference

Epitopes on protein antigens: misconceptions and realities.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Suppressive effect of antibody on processing of T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

The antigenic structure of proteins: a reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Relative roles of somatic and Darwinian evolution in shaping the antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Antibody-antigen complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Preparation and properties of bovine factor VIII (antihemophilic factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Inhibition of human factor VIIIa by anti-A2 subunit antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning Mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Structure of the C2 domain of human factor VIII at 1.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05342.X

10.1111/J.1423-0410.2002.TB05342.X

21 January 2018

Identifiers

DOI

0 references

1 reference